Compare CREX & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CREX | CCEL |
|---|---|---|
| Founded | N/A | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Managed Health Care |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.0M | 32.7M |
| IPO Year | N/A | 1997 |
| Metric | CREX | CCEL |
|---|---|---|
| Price | $3.22 | $3.41 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 61.9K | 14.0K |
| Earning Date | 03-13-2026 | 02-27-2026 |
| Dividend Yield | N/A | ★ 11.83% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $44,323,000.00 | $31,747,500.00 |
| Revenue This Year | $11.51 | $0.30 |
| Revenue Next Year | $83.66 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.28 | $3.10 |
| 52 Week High | $4.00 | $8.79 |
| Indicator | CREX | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | 52.11 | 38.45 |
| Support Level | $3.00 | $3.29 |
| Resistance Level | $3.43 | $3.57 |
| Average True Range (ATR) | 0.20 | 0.17 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 33.50 | 20.52 |
Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.